Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

Alex Z Fu,1 Shawn X Sun,2 Xingyue Huang,2 Alpesh N Amin31Georgetown University Medical Center, Washington, DC, 2Health Economics and Outcomes Research, Forest Laboratories, LLC, an affiliate of Actavis, Inc., Jersey City, NJ, 3Department of Medicine, University of California, Irvine, CA, USABackgrou...

Full description

Bibliographic Details
Main Authors: Fu AZ, Sun SX, Huang X, Amin AN
Format: Article
Language:English
Published: Dove Medical Press 2015-05-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/lower-30-day-readmission-rates-with-roflumilast-treatment-among-patien-peer-reviewed-article-COPD

Internet

http://www.dovepress.com/lower-30-day-readmission-rates-with-roflumilast-treatment-among-patien-peer-reviewed-article-COPD

Similar Items